Achilles Therapeutics (NASDAQ:ACHL – Free Report) had its target price reduced by Chardan Capital from $11.00 to $6.00 in a research report released on Friday, Benzinga reports. They currently have a buy rating on the stock. Other research analysts also recently issued reports about the company. Piper Sandler reissued a neutral rating and issued a […]
Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) is set to announce its earnings results on Tuesday, April 2nd. Achilles Therapeutics Stock Performance Shares of NASDAQ ACHL opened at $1.25 on Monday. The business has a fifty day simple moving average of $1.14 and a 200 day simple moving average of $0.96. The company has a […]
Bank of America reaffirmed their underperform rating on shares of Achilles Therapeutics (NASDAQ:ACHL – Free Report) in a report released on Thursday morning, Benzinga reports. Achilles Therapeutics Stock Up 1.2 % Shares of Achilles Therapeutics stock opened at $0.87 on Thursday. The firm’s 50 day moving average price is $0.86 and its 200-day moving average […]
Achilles Therapeutics (NASDAQ:ACHL – Get Free Report)‘s stock had its “underperform” rating reaffirmed by investment analysts at Bank of America in a research note issued to investors on Thursday, Benzinga reports. Achilles Therapeutics Trading Down 7.6 % Shares of NASDAQ:ACHL traded down $0.07 during midday trading on Thursday, hitting $0.89. 209,674 shares of the stock […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report)’s stock price shot up 1.8% during trading on Monday . The company traded as high as $0.85 and last traded at $0.84. 151,863 shares changed hands during trading, a decline of 10% from the average session volume of 167,858 shares. The stock had previously closed at $0.82. […]